Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants

References

• Esfahani K, Roudaia L, Buhlaiga N, Del Rincon SV, Papneja N, Miller WH. A review of cancer immunotherapy: from the past, to the present, to the future. Curr Oncol. 2020;27(12):87–15. doi:10.3747/co.27.5223.
   Web of Science ®Google Scholar
• Wculek SK, Cueto FJ, Mujal AM, Melero I, Krummel MF, Sancho D. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 2020;20(1):7–24. doi:10.1038/s41577-019-0210-z.
   PubMed Web of Science ®Google Scholar
• Garris CS, Arlauckas SP, Kohler RH, Trefny MP, Garren S, Piot C, Engblom C, Pfirschke C, Siwicki M, Gungabeesoon J, et al. Successful anti-PD-1 cancer immunotherapy requires T Cell-Dendritic cell crosstalk involving the cytokines IFN gamma and IL-12. Immunity. 2018;49(6):1148–1161. doi:10.1016/j.immuni.2018.09.024.
   PubMed Web of Science ®Google Scholar
• Spranger S, Dai D, Horton B, Gajewski TF. Tumor-Residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell. 2017;31(5):711–723. doi:10.1016/j.ccell.2017.04.003.
   PubMed Web of Science ®Google Scholar
• Salmon H, Idoyaga J, Rahman A, Leboeuf M, Remark R, Jordan S, Casanova-Acebes M, Khudoynazarova M, Agudo J, Tung N, et al. Expansion and activation of CD103+ dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF Inhibition. Immunity. 2016;44(4):924–938. doi:10.1016/j.immuni.2016.03.012.
   PubMed Web of Science ®Google Scholar
• Movassagh M, Spatz A, Davoust J, Lebecque S, Romero P, Pittet M, Rimoldi D, Liénard D, Gugerli O, Ferradini L, et al. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-Cell-Mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res. 2004;64(6):2192–2198. doi:10.1158/0008-5472.CAN-03-2969.
   PubMed Web of Science ®Google Scholar
• Truxova I, Kasikova L, Hensler M, Skapa P, Laco J, Pecen L, Belicova L, Praznovec I, Halaska MJ, Brtnicky T, et al. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. J Immunother Cancer. 2018;6(1):139. doi:10.1186/s40425-018-0446-3.
   PubMed Web of Science ®Google Scholar
• Michea P, Noël F, Zakine E, Czerwinska U, Sirven P, Abouzid O, Goudot C, Scholer-Dahirel A, Vincent-Salomon A, Reyal F, et al. Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific. Nat Immunol. 2018;19(8):885–897. doi:10.1038/s41590-018-0145-8.
   PubMedGoogle Scholar
• Verneau J, Sautés-Fridman C, Sun CM. Dendritic cells in the tumor microenvironment: prognostic and theranostic impact. Semin Immunol. 2020;48:101410. doi:10.1016/j.smim.2020.101410.
   PubMed Web of Science ®Google Scholar
• Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013;31(1):1–48. doi:10.1146/annurev-immunol-020711-074950.
   PubMed Web of Science ®Google Scholar
• Eisenbarth SC. Dendritic cell subsets in T cell programming: location dictates function. Nat Rev Immunol. 2019;19(2):89–103. doi:10.1038/s41577-018-0088-1.
   PubMed Web of Science ®Google Scholar
• Mitchell D, Chintala S, Dey M. Plasmacytoid dendritic cell in immunity and cancer. J Neuroimmunol. 2018;322:63–73. doi:10.1016/j.jneuroim.2018.06.012.
   PubMed Web of Science ®Google Scholar
• Domínguez PM, Ardavín C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev. 2010;234(1):90–104. doi:10.1111/j.0105-2896.2009.00876.x.
   PubMed Web of Science ®Google Scholar
• Gardner A, Ruffell B. Dendritic cells and cancer immunity. Trends Immunol. 2016;37(12):855–865. doi:10.1016/j.it.2016.09.006.
   PubMed Web of Science ®Google Scholar
• Huber A, Dammeijer F, Aerts JGJV, Vroman H. Current state of dendritic cell-Based immunotherapy: opportunities for in vitro antigen loading of different DC subsets? Front Immunol. 2018;9:2804. doi:10.3389/fimmu.2018.02804.
   PubMed Web of Science ®Google Scholar
• Russell L, Peng KW, Russell SJ, Diaz RM. Oncolytic viruses: priming time for cancer immunotherapy. BioDrugs. 2019;33(5):485–501. doi:10.1007/s40259-019-00367-0.
   PubMed Web of Science ®Google Scholar
• Felt SA, Grdzelishvili VZ. Ecent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update. J Gen Virol. 2017;98(12):2895–2911. doi:10.1099/jgv.0.000980.
   PubMed Web of Science ®Google Scholar
• Muik A, Stubbert LJ, Jahedi RZ, Geib Y, Kimpel J, Dold C, Tober R, Volk A, Klein S, Dietrich U, et al. Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency. Cancer Res. 2014;74(13):3567–3578. doi:10.1158/0008-5472.CAN-13-3306.
   PubMed Web of Science ®Google Scholar
• Dold C, Rodriguez Urbiola C, Wollmann G, Egerer L, Muik A, Bellmann L, Fiegl H, Marth C, Kimpel J, von Laer D, et al. Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy. Mol Ther — Oncolytics. 2016;3:16021. doi:10.1038/mto.2016.21.
   PubMed Web of Science ®Google Scholar
• Kimpel J, Urbiola C, Koske I, Tober R, Banki Z, Wollmann G, von Laer D. The oncolytic virus VSV-GP is effective against malignant melanoma. Viruses. 2018;10(3):1–16. doi:10.3390/v10030108.
   Web of Science ®Google Scholar
• Urbiola C, Santer FR, Petersson M, van der Pluijm G, Horninger W, Erlmann P, Wollmann G, Kimpel J, Culig Z, von Laer D, et al. Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer. Int J Cancer. 2018;143(7):1786–1796. doi:10.1002/ijc.31556.
   PubMed Web of Science ®Google Scholar
• Schreiber LM, Urbiola C, Das K, Spiesschaert B, Kimpel J, Heinemann F, Stierstorfer B, Müller P, Petersson M, Erlmann P, et al. The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer. Br J Cancer. 2019;121(8):647–658. doi:10.1038/s41416-019-0574-7.
   PubMed Web of Science ®Google Scholar
• Tober R, Banki Z, Egerer L, Muik A, Behmuller S, Kreppel F, Greczmiel U, Oxenius A, von Laer D, Kimpel J, et al. VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications. J Virol. 2014;88(9):4897–4907. doi:10.1128/JVI.03276-13.
   PubMed Web of Science ®Google Scholar
• Wilmschen S, Schneider S, Peters F, Bayer L, Issmail L, Bánki Z, Laer V. RSV vaccine based on rhabdoviral vector protects after single immunization. Vaccines. 2019;7(3):59. doi:10.3390/vaccines7030059.
   Web of Science ®Google Scholar
• Gujar SA, Lee PWK. Oncolytic virus-mediated reversal of impaired tumor antigen presentation. Front Oncol. 2014;4:1–7. doi:10.3389/fonc.2014.00077.
   PubMedGoogle Scholar
• Kim Y, Clements DR, Sterea AM, Jang HW, Gujar SA, Lee PWK. Dendritic cells in oncolytic virus-based anti-cancer therapy. Viruses. 2015;7(12):6506–6525. doi:10.3390/v7122953.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Mckenzie MO, Puckett S, Hojnacki M, Poliquin L, Lyles DS. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and Protein Synthesis Ability of the Matrix Protein of Vesicular Stomatitis Virus To Suppress. J Virol. 2003;77(8):4646. doi:10.1128/JVI.77.8.4646-4657.2003.
   PubMed Web of Science ®Google Scholar
• Westcott MM, Ahmed M, Smedberg JR, Rajani KR, Hiltbold EM, Lyles DS. Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein. J Virol. 2013;87(21):11730–11740. doi:10.1128/JVI.00680-13.
   PubMed Web of Science ®Google Scholar
• Frenz T, Graalmann L, Detje CN, Döring M, Grabski E, Scheu S, Kalinke U. Independent of Plasmacytoid Dendritic Cell (pDC) infection, pDC triggered by virus-infected cells mount enhanced type I IFN responses of different composition as opposed to pDC stimulated with free virus. J Immunol. 2014;193(5):2496–2503. doi:10.4049/jimmunol.1400215.
   PubMed Web of Science ®Google Scholar
• Jayakar HR, Whitt MA. Identification of two additional translation products from the matrix (M) gene that contribute to vesicular stomatitis virus cytopathology. J Virol. 2002;76(16):8011–8018. doi:10.1128/JVI.76.16.8011-8018.2002.
   PubMed Web of Science ®Google Scholar
• Stojdl DF, Lichty BD, TenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell. 2003;4(4):263–275. doi:10.1016/S1535-6108(03)00241-1.
   PubMed Web of Science ®Google Scholar
• Wollmann G, Rogulin V, Simon I, Rose JK, van den Pol AN. van den Pol AN. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells. J Virol. 2010;84(3):1563–1573. doi:10.1128/JVI.02040-09.
   PubMed Web of Science ®Google Scholar
• Muik A, Kneiske I, Werbizki M, Wilflingseder D, Giroglou T, Ebert O, Kraft A, Dietrich U, Zimmer G, Momma S, et al. Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism. J Virol. 2011;85(11):5679–5684. doi:10.1128/JVI.02511-10.
   PubMed Web of Science ®Google Scholar
• Bánki Z, Kacani L, Müllauer B, Wilflingseder D, Obermoser G, Niederegger H, Schennach H, Sprinzl GM, Sepp N, Erdei A, et al. Cross-Linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-κB signaling pathway. J Immunol. 2003;170(8):3963–3970. doi:10.4049/jimmunol.170.8.3963.
   PubMed Web of Science ®Google Scholar
• Lutz MB, Kukutsch N, Ogilvie ALJ, Rößner S, Koch F, Romani N, Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999;223(1):77–92. doi:10.1016/S0022-1759(98)00204-X.
   PubMed Web of Science ®Google Scholar
• Schreiber L-M, Urbiola C, Erlmann P, Wollmann G. In Vivo Bioimaging for Monitoring Intratumoral Virus Activity. In: Engeland C. (eds) Oncolytic Viruses. Methods in Molecular Biology,  Chapter 15, vol 2058. New York: Humana. 2020.  p. 237–248.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Lagadic-Gossmann D, Huc L, Lecureur V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ. 2004;11(9):953–961. doi:10.1038/sj.cdd.4401466.
   PubMed Web of Science ®Google Scholar
• Shinoda H, Shannon M, Nagai T. Fluorescent proteins for investigating biological events in acidic environments. Int J Mol Sci. 2018;19(6):1548. doi:10.3390/ijms19061548.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Brzoza KL, Hiltbold EM. Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells. J Virol. 2006;80(5):2194–2205. doi:10.1128/JVI.80.5.2194-2205.2006.
   PubMed Web of Science ®Google Scholar
• Bart RS, Porzio NR, Kopf AW, Cheng EH, Farcet Y, Vilcek JT. Inhibition of growth of b16 murine malignant melanoma by exogenous interferon. Cancer Res. 1980;40:614–619.
   PubMed Web of Science ®Google Scholar
• Collin M, Bigley V. Human dendritic cell subsets: an update. Immunology. 2018;154(1):3–20. doi:10.1111/imm.12888.
   PubMed Web of Science ®Google Scholar
• Nikitina E, Larionova I, Choinzonov E, Kzhyshkowska J. Monocytes and macrophages as viral targets and reservoirs. Int J Mol Sci. 2018;19(9):2821. doi:10.3390/ijms19092821.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Mitchell LM, Puckett S, Brzoza-Lewis KL, Lyles DS, Hiltbold EM. Vesicular stomatitis virus M protein mutant stimulates maturation of toll-Like receptor 7 (TLR7)-Positive dendritic cells through TLR-Dependent and -Independent mechanisms. J Virol. 2009;83(7):2962–2975. doi:10.1128/JVI.02030-08.
   PubMed Web of Science ®Google Scholar
• Boudreau JE, Bridle BW, Stephenson KB, Jenkins KM, Brunellière J, Bramson JL, Lichty BD, Wan Y. Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity. Mol Ther. 2009;17(8):1465–1472. doi:10.1038/mt.2009.95.
   PubMed Web of Science ®Google Scholar
• Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Henry MD, Borrow P, Yamada H, Elder JH, et al. Identification of α-Dystroglycan as a receptor for lymphocytic choriomeningitis virus and lassa fever virus. Science. 1998;282(5396):2079–2081. (80-). doi:10.1126/science.282.5396.2079.
   PubMed Web of Science ®Google Scholar
• Finkelshtein D, Werman A, Novick D, Barak S, Rubinstein M. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc Natl Acad Sci. 2013;110(18):7306–7311. doi:10.1073/pnas.1214441110.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Kiihn U, Miiller G, Steinbrink K, Paragnik L, Schmitp E, Knop J, Enk AH. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions European Journal of immunology wiley online library. Eur J Immunol. 1997;27(12):3135–3142. doi:10.1002/eji.1830271209.
   PubMed Web of Science ®Google Scholar
• Maney NJ, Reynolds G, Krippner-heidenreich A, Catharien MU. Dendritic cell maturation and survival are differentially regulated by TNF receptors 1 and 21. J Immunol. 2016;193(10):4914–4923. doi:10.4049/jimmunol.1302929.
   Web of Science ®Google Scholar
• Gschwandtner M, Derler R, Midwood KS. More than just attractive: how CCL2 influences myeloid cell behavior beyond chemotaxis. Front Immunol. 2019;10:1–29.
   PubMed Web of Science ®Google Scholar
• Honda K, Sakaguchi S, Nakajima C, Watanabe A, Yanai H, Matsumoto M, Ohteki T, Kaisho T, Takaoka A, Akira S, et al. Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc Natl Acad Sci U S A. 2003;100(19):10872–10877. doi:10.1073/pnas.1934678100.
   PubMed Web of Science ®Google Scholar
• Pantel A, Teixeira A, Haddad E, Wood EG, Steinman RM, Longhi MP. Direct Type I IFN but Not MDA5/TLR3 Activation of dendritic cells is required for maturation and metabolic shift to glycolysis after poly IC stimulation. PLoS Biol. 2014;12(1):e1001759. doi:10.1371/journal.pbio.1001759.
   PubMed Web of Science ®Google Scholar
• Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+T cells. Immunity. 2002;16(6):779–790. doi:10.1016/S1074-7613(02)00324-2.
   PubMed Web of Science ®Google Scholar
• Honke N, Shaabani N, Cadeddu G, Sorg UR, Zhang DE, Trilling M, Klingel K, Sauter M, Kandolf R, Gailus N, et al. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol. 2012;13(1):51–57. doi:10.1038/ni.2169.
   Web of Science ®Google Scholar
• Naumenko V, Van S, Dastidar H, Kim DS, Kim SJ, Zeng Z, Deniset J, Lau A, Zhang C, Macia N, et al. Visualizing oncolytic Virus-Host interactions in live mice using intravital microscopy. Mol Ther - Oncolytics. 2018;10:14–27. doi:10.1016/j.omto.2018.06.001.
   PubMed Web of Science ®Google Scholar
• Beyer WR, Miletic H, Ostertag W, von Laer D. Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference. J Virol. 2001;75(2):1061–1064. doi:10.1128/JVI.75.2.1061-1064.2001.
   PubMed Web of Science ®Google Scholar
• Hastie KM, Igonet S, Sullivan BM, Legrand P, Zandonatti MA, Robinson JE, Garry RF, Rey FA, Oldstone MB, Saphire EO, et al. Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV. Nat Struct Mol Biol. 2016;23(6):513–521. doi:10.1038/nsmb.3210.
   PubMed Web of Science ®Google Scholar
• Sevilla N, Kunz S, Holz A, Lewicki H, Homann D, Yamada H, Campbell KP, de la Torre JC, Oldstone MBA. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J Exp Med. 2000;192(9):1249–1260. doi:10.1084/jem.192.9.1249.
   PubMed Web of Science ®Google Scholar
• Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MBA. Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J Cell Biol. 2001;155(2):301–310. doi:10.1083/jcb.200104103.
   PubMed Web of Science ®Google Scholar
• Oldstone MBA, Campbell KP. Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response. Virology. 2011;411(2):170–179. doi:10.1016/j.virol.2010.11.023.
   PubMed Web of Science ®Google Scholar
• Iannacone M, Moseman EA, Tonti E, Bosurgi L, Junt T, Henrickson SE, Whelan SP, Guidotti LG, von Andrian UH. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature. 2010;465(7301):1079–1083. doi:10.1038/nature09118.
   PubMed Web of Science ®Google Scholar
• Shaabani N, Duhan V, Khairnar V, Gassa A, Ferrer-Tur R, Häussinger D, Recher M, Zelinskyy G, Liu J, Dittmer U, et al. CD169+ macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infection. Cell Death Dis. 2016;7(11):e2446. doi:10.1038/cddis.2016.350.
   PubMed Web of Science ®Google Scholar
• Veglia F, Gabrilovich DI. Dendritic cells in cancer : the role revisited. Curr Opin Immunol. 2018;45:43–51. doi:10.1016/j.coi.2017.01.002.
   Web of Science ®Google Scholar
• Leveille S, Goulet M-L, Lichty BD, Hiscott J. Vesicular stomatitis virus oncolytic treatment interferes with tumor-associated dendritic cell functions and abrogates tumor antigen presentation. J Virol. 2011;85(23):12160–12169. doi:10.1128/JVI.05703-11.
   PubMed Web of Science ®Google Scholar
• Mennechet FJD, Uzé G. Interferon-λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood. 2006;107(11):4417–4423. doi:10.1182/blood-2005-10-4129.
   PubMed Web of Science ®Google Scholar
• Swiecki M, Wang Y, Vermi W, Gilfillan S, Schreiber RD, Colonna M. Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo. J Exp Med. 2011;208(12):2367–2374. doi:10.1084/jem.20110654.
   PubMed Web of Science ®Google Scholar
• Webster B, Assil S, Dreux M, Pfeiffer J. Cell-Cell sensing of viral infection by plasmacytoid dendritic cells. J Virol. 2016;90(22):10050–10053. doi:10.1128/JVI.01692-16.
   PubMed Web of Science ®Google Scholar
• Hou W, Gibbs JS, Lu X, Brooke CB, Roy D, Modlin RL, Bennink JR, Yewdell JW. Viral infection triggers rapid differentiation of human blood monocytes into dendritic cells. Blood. 2012;119(13):3128–3131. doi:10.1182/blood-2011-09-379479.
   PubMed Web of Science ®Google Scholar
• Tomczyk T, Wróbel G, Chaber R, Siemieniec I, Piasecki E, Krzystek-Korpacka M, Orzechowska BU. Immune consequences of in vitro infection of human peripheral blood leukocytes with vesicular stomatitis virus. J Innate Immun. 2018;10(2):131–144. doi:10.1159/000485143.
   PubMed Web of Science ®Google Scholar
• Jakubzick CV, Randolph GJ, Henson PM. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol. 2017;17(6):349–362. doi:10.1038/nri.2017.28.
   PubMed Web of Science ®Google Scholar